Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?

Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries

(2016) Anna Vassall et al.   HEALTH ECONOMICS

Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review

(2016) Tom L. Drake et al.   HEALTH ECONOMICS

Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature

(2016) Catherine Pitt et al.   HEALTH ECONOMICS

Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale

(2016) Lucy Cunnama et al.   HEALTH ECONOMICS

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

(2015) Karl Claxton et al.   HEALTH TECHNOLOGY ASSESSMENT

Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development

(2015) Benjarin Santatiwongchai et al.   PLoS One

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.

(2014) AK Ewer et al.   HEALTH TECHNOLOGY ASSESSMENT

Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease

(2014) Seema Kacker et al.   TRANSFUSION

Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services

(2013) Starley B. Shade et al.   AIDS

Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations

(2013) Sharmini Selvarajah et al.   BMC Cardiovascular Disorders

Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review

(2013) Amir Shroufi et al.   BMC PUBLIC HEALTH

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand

(2013) Waranya Rattanavipapong et al.   EPILEPSIA

PRIORITY SETTING IN GLOBAL HEALTH: TOWARDS A MINIMUM DALY VALUE

(2013) Tom Drake   HEALTH ECONOMICS

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?

(2013) Wantanee Kulpeng et al.   VACCINE

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

(2013) Don Husereau et al.   VALUE IN HEALTH

A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries

(2012) Marc Suhrcke et al.   BMC PUBLIC HEALTH

Crossing the fourth hurdle

(2012) Michael D. Rawlins   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

(2012) Joshua A Salomon et al.   LANCET

Costs and Cost-Effectiveness of a Mobile Phone Text-Message Reminder Programmes to Improve Health Workers' Adherence to Malaria Guidelines in Kenya

(2012) Dejan Zurovac et al.   PLoS One

Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern Nigeria

(2012) Charles Ezenduka et al.   PLoS Neglected Tropical Diseases

Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review

(2011) ChiHui Fang et al.   VALUE IN HEALTH

A Bibliometric Review of Cost-Effectiveness Analyses in the Economic and Medical Literature: 1976-2006

(2010) Dan Greenberg et al.   MEDICAL DECISION MAKING

30 Years of Pharmaceutical Cost-Utility Analyses

(2009) Peter J. Neumann et al.   PHARMACOECONOMICS

Cost Effectiveness in Low- and Middle-Income Countries

(2009) Samuel D. Shillcutt et al.   PHARMACOECONOMICS

WHO Guide for standardisation of economic evaluations of immunization programmes

(2009) Damian G. Walker et al.   VACCINE

Lessons for Health Technology Assessment: It Is Not Only about the Evidence

(2009) Peter J. Neumann   VALUE IN HEALTH

Health Technology Assessment: Lessons Learned from Around the World—An Overview

(2009) John C. O'Donnell et al.   VALUE IN HEALTH

Economic evaluations ofHaemophilus influenzaetype b vaccine: systematic review of the literature

(2009) Ulla K Griffiths et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Increasing decision-makers' access to economic evaluations: Alternative methods of communicating the information

(2008) Stephanie J. Thurston et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE